ALIGNMENT HEALTHCARE INC (ALHC)
US01625V1044 - Common Stock
Taking everything into account, ALHC scores 2 out of 10 in our fundamental rating. ALHC was compared to 117 industry peers in the Health Care Providers & Services industry. ALHC has a bad profitability rating. Also its financial health evaluation is rather negative. ALHC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ALHC had negative earnings in the past year.
ALHC had a negative operating cash flow in the past year.
In the past 5 years ALHC always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALHC reported negative operating cash flow in multiple years.
1.2 Ratios
ALHC has a Return On Assets of -25.01%. This is in the lower half of the industry: ALHC underperforms 76.72% of its industry peers.
Looking at the Return On Equity, with a value of -94.31%, ALHC is doing worse than 74.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.01% | ||
| ROE | -94.31% | ||
| ROIC | N/A |
ROA(3y)-26.52%
ROA(5y)-21.89%
ROE(3y)-73.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of ALHC (11.02%) is worse than 78.45% of its industry peers.
ALHC's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALHC so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.99%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALHC has been increased compared to 1 year ago.
Compared to 1 year ago, ALHC has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.08 indicates that ALHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALHC has a Altman-Z score (2.08) which is in line with its industry peers.
ALHC has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
ALHC has a worse Debt to Equity ratio (1.03) than 62.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.08 |
ROIC/WACCN/A
WACC9.3%
2.3 Liquidity
ALHC has a Current Ratio of 1.84. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
ALHC has a Current ratio of 1.84. This is in the better half of the industry: ALHC outperforms 73.28% of its industry peers.
A Quick Ratio of 1.84 indicates that ALHC should not have too much problems paying its short term obligations.
ALHC's Quick ratio of 1.84 is fine compared to the rest of the industry. ALHC outperforms 75.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.84 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.88% over the past year.
Looking at the last year, ALHC shows a very strong growth in Revenue. The Revenue has grown by 27.17%.
The Revenue has been growing by 23.88% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.88%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q19.35%
Revenue 1Y (TTM)27.17%
Revenue growth 3Y23.88%
Revenue growth 5YN/A
Revenue growth Q2Q28.63%
3.2 Future
ALHC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.58% yearly.
The Revenue is expected to grow by 21.97% on average over the next years. This is a very strong growth
EPS Next Y37.25%
EPS Next 2Y27.78%
EPS Next 3Y-5.53%
EPS Next 5Y16.58%
Revenue Next Year21.46%
Revenue Next 2Y24.13%
Revenue Next 3Y25.6%
Revenue Next 5Y21.97%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALHC. In the last year negative earnings were reported.
Also next year ALHC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALHC's earnings are expected to decrease with -5.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.78%
EPS Next 3Y-5.53%
5. Dividend
5.1 Amount
ALHC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ALIGNMENT HEALTHCARE INC
NASDAQ:ALHC (4/25/2024, 3:30:01 PM)
After market: 5.16 0 (0%)5.16
-0.02 (-0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap975.14M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -25.01% | ||
| ROE | -94.31% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 11.02% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.03 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.84 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)4.88%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y37.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.17%
Revenue growth 3Y23.88%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y